A study from the UK and Canada followed more than 2500 patients with Barrett’s Esophagus for an average of 9 years, and divided them into two groups: Nexium 20 mg a day and Nexium 40 mg twice a day. The high dose group had fewer numbers of esophageal cancer or High Grade Dysplasia (a precursor
Read More